Simpson Thacher discusses SEC Charges against CVS for Misleading Investors Through Materially Misleading Disclosures and Use of Improper Accounting
On April 8, 2014, the Securities and Exchange Commission (“SEC”) charged CVS Caremark Corp. (“CVS”) with violating the federal securities laws by failing to accurately disclose significant financial setbacks and overstating its financial performance through improper accounting.[1] CVS, which has …